Medicine and Dentistry
Pregnancy-Associated Plasma Protein A
81%
Growth Hormone
54%
Adult
54%
Leptin
45%
Growth Hormone Deficiency
45%
Adiponectin
36%
Body Mass Index
27%
Therapeutic Procedure
27%
Lipid
18%
Combination Therapy
18%
Fibrinogen
18%
Glucose Homeostasis
18%
Patient
18%
Metabolism
9%
Proteinase
9%
Age
9%
Cardiovascular Risk
9%
Substitution Therapy
9%
C Reactive Protein
9%
Adverse Event
9%
Intima-Media Thickness
9%
Homeostatic Model Assessment
9%
Waist-Hip Ratio
9%
Resistance Index
9%
Vascular Tissue
9%
Marker
9%
Sex
9%
Endocrinology
9%
Neuroscience
Growth Hormone Treatment
100%
Pregnancy Associated Plasma Protein A
81%
Leptin
45%
Adiponectin
36%
Body Mass Index
27%
Fibrinogen
18%
Predictor
18%
C-Reactive Protein
9%
Endocrinology
9%
Proteinase
9%
Insulin
9%
Adverse Effect
9%
Pharmacology, Toxicology and Pharmaceutical Science
Pregnancy Associated Plasma Protein A
81%
Growth Hormone
54%
Leptin
45%
Growth Hormone Deficiency
45%
Adiponectin
36%
Lipid
18%
Fibrinogen
18%
Proteinase
9%
Adverse Event
9%
C Reactive Protein
9%
Insulin
9%
Cardiovascular Risk
9%
Atherosclerosis
9%
Biochemistry, Genetics and Molecular Biology
Leptin
45%
Adiponectin
36%
Body Mass
27%
Lipid Profile
18%
Glucose Homeostasis
18%
Fibrinogen
18%
Insulin
9%
Metabolic Pathway
9%
Insulin Resistance
9%
C-Reactive Protein
9%
Homeostasis
9%
Body Composition
9%
Age
9%
Waist Hip Ratio
9%
Thickness
9%
Sex
9%
Immunology and Microbiology
Adiponectin
36%
Body Mass
27%
Fibrinogen
18%
Glucose Homeostasis
18%
Metabolism
9%
C-Reactive Protein
9%
Atherosclerosis
9%
Homeostasis
9%
Body Composition
9%
Age
9%
Insulin Resistance
9%
Vascular Tissue
9%
Sex
9%
Thickness
9%
Waist Hip Ratio
9%